Kefir extracts suppress in vitro proliferation of estrogen-dependent human breast cancer cells but not normal mammary epithelial cells

Journal of Medicinal Food

Volumn 10, Issue 3, 2007, Pages 416-422

  Chen, Chujian ^a,c   Hing, Man Chan ^b   Kubow, Stan ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF NORTHERN BRITISH COLUMBIA   (Canada)

^c NANTONG UNIVERSITY   (China)

Author keywords

Fermentation; Human MCF 7 breast cancer cells; Kefir; Peptides; Proliferation

Indexed keywords

ESTROGEN; YOGHURT;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CAPILLARY ELECTROPHORESIS; CELL PROLIFERATION; CELL STRAIN MCF 7; COMPARATIVE STUDY; CONTROLLED STUDY; EXTRACT; FERMENTED PRODUCT; HUMAN; HUMAN CELL; IN VITRO STUDY; KEFIR; MILK; PRIORITY JOURNAL;

ANIMALS; BREAST; BREAST NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; CULTURED MILK PRODUCTS; EPITHELIAL CELLS; FERMENTATION; HUMANS; MILK; MILK PROTEINS; PEPTIDES; YOGURT;

ANIMALIA;

EID: 34848890327     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2006.236     Document Type: Article

References (29)

1. Reddy GV, Friend BA, Shahani KM, Farmer RE: Antitumor activity of yogurt components. J Food Protect 1983;46:8-11.
2. Veer P, Dekker JM, Lamars JWJ, Kok FJ, Schouten EG: Consumption of fermented milk products and breast cancer: a case-control study in the Netherlands. Cancer Res 1989;49:4020-4023.
3. Cassand P, Abdelali H, Bouley C, Denariaz G, Narbonne JF: Inhibitory effect of dairy products on the mutagenicities of chemicals and dietary mutagens. J Dairy Res 1994;61:545-552.
4. Abdelali H, Cassand P, Soussotte V, Bocabeille BK, Narbonne JF: Antimutagenicity of components of dairy products. Mutat Res 1995;331:133-141.
5. Hosono A, Wardojo R, Otani H: Inhibitory effects of lactic acid bacteria from fermented milk on the mutagenicities of volatile nitrosamines. Agric Biol Chem 1990;54:1639-1643.
6. Renner HW, Munzner R: The possible role of probiotics as dietary antimutagens. Mutat Res 1991;262:239-245.
7. Pol-Zobel BL, Munzner R, Holzafel WH: Antigenotoxic properties of lactic acid bacteria in the Salmonella typhimurium mutagenicity assay. Nutr Cancer 1993;20:261-270.
8. Bourtourault M, Buleon R, Samperez S, Jouan P: Effet des proteines du lactoserum bovin sur la multiplication de cellules cancereuses humaines. C R Soc Biol 1991;185:319-323.
9. McIntosh GH, Regester GO, Leu LE: Dairy proteins protect against dimethylhydrazine-induced intestinal cancers in rats. J Nutr 1995;125:809-816.
10. Svensson M, Sabharwal H, Mossberg AK, Lipniunas P, Leffler H, Svanborg C, Linse S: Molecular characterization of alpha-lactalbumin folding variants that induce apoptosis in tumor cells. J Biol Chem 1999;274:6388-6396.
11. Shiomi M, Sasaki K, Murofushi M, Aibara K: Antitumor activity in mice orally administrated polysaccharide from kefir grains. Jpn J Med Sci Biol 1982;35:75-80.
12. Koroleva NS: Technology of kefir and kumy. IDF Bull 1988;227:96-100.
13. Olesmall ME, Nicheno EV, Mitrokhin SD, Nonikov VE, Minaev VI: Effectiveness of acipole in prevention of enteric dysbacteriosis due to antibacterial therapy. Antibiotiki I Khimioterapii 1999;44:23-25.
14. Komai M, Nanno M: Intestinal microflora and longevity. In: Functions of Fermented Milk (Nakazawa Y, Hosono A, eds.), Elsevier Applied Science, London, 1992, pp. 343-346.
15. Bottazzi V, Zacconi C, Sarra PG, Dallavalle P, Parisi MG: Kefir-microbiology, chemistry and technology. Ind Latte 1994;30:41-62.
16. Cevikbas A, Yemni E, Ezzedenn FW, Yardimici T: Antitumoural, antibacterial and antifungal activities of kefir and kefir grain. Phytother Res 1994;8:78-82.
17. Furukawa N, Matsuoka A, Yamanaka Y: Effects of orally administrated yogurt and kefir on tumor growth in mice. J Jpn Soc Nutr Food Sci 1990;43:450-453.
18. Kubo M, Odani T, Nakamura S: Pharmacological study on kefir - a fermented milk product in Caucasus. I. On antitumor activity (1). Yakugaku Zasshi 1992;112:489-495.
19. Wade MG, Desaulniers D, Leingartner K, Foster WG: Interactions between endosulfan and dieldrin on estrogen-mediated processes in vitro and in vivo. Reprod Toxicol 1997;11:791-798.
20. Church FC, Swaisgood HE, Porter DH, Catinani GL: Spectrophotometric assay using o-phthaldialdehyde for determination of proteolysis in milk and isolation milk proteins. J Dairy Sci 1983;66:1219-1227.
21. Biffi A, Coradini D, Larsen R, Riva L, Di Fronzo G: Antiproliferative effect of fermented milk on the growth of a human breast cancer cell line. Nutr Cancer 1997;28:93-99.
22. Ganjam LS, Thornton WH, Marshall RT, MacDonald RS: Antiproliferative effects of yogurt fractions obtained by membrane dialysis on cultured mammalian intestinal cells. J Dairy Sci 1997;80:2325-2329.
23. Hakimuddin F, Paliyath G, Meckling K: Selective cytotoxicity of a red grape wine flavonoid fraction against MCF-7 cells. Breast Cancer Res Treat 2004;85:65-79.
24. Laursen I, Briand P, Lykkesfeldt AE: Serum albumin as a modulator on growth of the human breast cancer cell line, MCF-7. Anticancer Res 1990;10:343-352.
25. Yoo YC, Watanabe R, Koike Y: Apoptosis in human leukemic cells induced by lactoferricin, a bovine milk protein-derived peptide: involvement of reactive oxygen species. Biochem Biophys Res Commun 1997;237:624-628.
26. Fuglsang A, Rattray FP, Nilsson D, Nyborg NCB: Lactic acid bacteria: inhibition of angiotensin converting enzyme in vitro and in vivo. Antonie van Leeuwenhoek 2003;83:27-34.
27. Hannun YA: The sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem 1994;269:3125-3128.
28. Merrill AH, Schmelz EM, Dillehay DL, Spiegel S, Shayman JA, Schroder JJ, Riley RT, Voss KA, Wang E: Sphingolipids - the enigmatic lipid class: biochemistry, physiology, and pathophysiology. Toxicol Appl Pharmacol 1997;142:208-225.
29. Osada K, Nagira K, Teruya K, Tachibana H, Shirahata S, Murakami H: Enhancement of interferon-beta production with sphingomyelin from fermented milk. Biotherapy 1993;7:115-123.